Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

ClinicalTrials.gov ID: NCT01543204

Public ClinicalTrials.gov record NCT01543204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 10:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Lost a Satisfactory Response to Adalimumab

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy of etanercept in patients with plaque psoriasis who have lost a satisfactory response to adalimumab.

Study identification

NCT ID
NCT01543204
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
64 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 1, 2012 (Actual)
Primary completion
May 29, 2015 (Actual)
Completion
May 29, 2015 (Actual)
Last update posted
Dec 29, 2017

2012 – 2015

United States locations

U.S. sites
42
U.S. states
23
U.S. cities
41
Facility City State ZIP Site status
Research Site Birmingham Alabama 35205 —
Research Site Mobile Alabama 36609 —
Research Site Phoenix Arizona 85044 —
Research Site Bakersfield California 93309 —
Research Site Encino California 91436 —
Research Site Irvine California 92697 —
Research Site Los Angeles California 90045 —
Research Site Sacramento California 95816 —
Research Site San Francisco California 94118 —
Research Site San Ramon California 94583 —
Research Site Santa Monica California 90404 —
Research Site Denver Colorado 80220 —
Research Site Farmington Connecticut 06030 —
Research Site Jacksonville Florida 32204 —
Research Site Miami Florida 33136 —
Research Site St. Petersburg Florida 33708 —
Research Site Tampa Florida 33607 —
Research Site Tampa Florida 33609 —
Research Site Atlanta Georgia 30342 —
Research Site Macon Georgia 31217 —
Research Site Skokie Illinois 60077 —
Research Site New Albany Indiana 47150 —
Research Site Plainfield Indiana 46168 —
Research Site Louisville Kentucky 40202 —
Research Site New Orleans Louisiana 70112 —
Research Site Boston Massachusetts 02115 —
Research Site St Louis Missouri 63117 —
Research Site Omaha Nebraska 68144 —
Research Site East Windsor New Jersey 08520 —
Research Site Verona New Jersey 07044 —
Research Site Rochester New York 14625 —
Research Site Pittsburgh Pennsylvania 15213 —
Research Site Plymouth Meeting Pennsylvania 19462 —
Research Site Johnston Rhode Island 02919 —
Research Site Charleston South Carolina 29414 —
Research Site Bartlett Tennessee 38134 —
Research Site Knoxville Tennessee 37917 —
Research Site Nashville Tennessee 37215 —
Research Site Dallas Texas 75231 —
Research Site Houston Texas 77004 —
Research Site Norfolk Virginia 23507 —
Research Site Walla Walla Washington 99362 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01543204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 29, 2017 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01543204 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →